Home

Results 41 - 50 of 451,583 for medical products. Search took 1.05 seconds.  
Sort by date/Sort by relevance
Batch Number: is the special number of a batch product. 17. Label: is a card containing the name, medical type, terms of maintenance, quantity and medical ingredients, batch number, date of product, expiry date, name and address of producing company, and is planted on the vessel or package. 18. Package: the practice of putting final medical products and other medical equipments in certain packages in order to ensure the safe transportation and avoid demolition (contains some information). 19. (...) Production, import and supply of medicine which are not in the legal list Article 9: (1) Production, import and supply of medicine and medical equipments which are not in the legal medicine list, is not allowed. (2) Production, import and supply of medicine and medical equipments which are not in the legal medicine list, can be allowed in special cases with proposal of Pharmacy Affairs Department and approve of National Medical Board.
Language:English
Score: 838644.9 - https://www.wto.org/english/th...e/afg_e/WTACCAFG5A1_LEG_21.pdf
Data Source: un
"The South-East Asia Regulatory Network’s efforts to increase access to quality medical products is crucial to achieving universal health coverage and the Sustainable Development Goals to ensure healthy lives and promote health and well-being for all, at all ages,” Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region, said here. (...) The meeting will also review progress made on quality assurance & standards of medical products; regulatory practices; vigilance of medical products; an Information Sharing Platform and medical devices and diagnostics. (...) “As the ISP matures, I trust you will share alerts and confidential information to ensure quality medical products reach all people everywhere in our very large and diverse region.
Language:English
Score: 838123.4 - https://www.who.int/southeasta...uality-of-medical-products-who
Data Source: un
The intended primary mode of action of a medical device on the human body, in contrast with that of medicinal products, is not metabolic, immunological, or pharmacological. (...) Product representation: the third critical element Pre-market review contributes to product control, and post-market surveillance ensures that medical devices in use continue to be safe and effective. (...) User/public education is key in guarding against misrepresentation. REPRESENTATION OF PRODUCT TO USER PRODUCT USE PRODUCT USE 10 MEDICAL DEVICE REGULATIONS 3.2 Stages of regulatory control We can identify the control of these three critical elements by relating them to the now familiar Life Span diagram shown below.
Language:English
Score: 838010 - https://www.who.int/medical_de...ications/en/MD_Regulations.pdf
Data Source: un
South-East Asia Bangladesh Home Health topics Our work News Emergencies About us Home / News / Detail / Steps to ensure safe, quality and effective medical products in Bangladesh Steps to ensure safe, quality and effective medical products in Bangladesh 15 June 2017 Highlights Dhaka Bangladesh is currently taking important steps for improving the regulation of medical products, aiming to increase their safety, quality and efficacy across the country. (...) A coalition of development organizations was created based on discussions with DGDA to strengthen the regulatory system of medical products. Nine teams have been formed to assess nine regulatory functions based on the National Regulator Authority (NRA) as essential mechanisms for reforming the framework of medical products regulation. (...) Media Contacts Catalin-Constantin Bercaru WHO Country Office Bangladesh Email: [email protected] News WHO started prepositioning of medical supplies in Cox’s Bazar 27 September 2017 Bangladesh steps up efforts to control quality of medical products 3 March 2019 Coalition of Interested Partners reiterates support for strengthening medicine regulatory affairs 30 October 2018 Quick links Media centre Head of WHO Office Procurement Careers Regional links Data Publications Help Contact us Email scams Privacy Integrity Hotline Privacy Legal Notice © 2022 WHO
Language:English
Score: 837958.6 - https://www.who.int/bangladesh...medical-products-in-bangladesh
Data Source: un
Select language Select language English South-East Asia India Home Health topics Our work News Emergencies About us Home / News / Detail / Union Health Minister inaugurates ‘1st World Conference on Access to Medical Products and International Laws for Trade and Health’ Union Health Minister inaugurates ‘1st World Conference on Access to Medical Products and International Laws for Trade and Health’ 16 November 2017 Highlights Inaugurating the First World Conference on "Access to Medical Products and International Laws for Trade and Health in the Context of the 2030 Agenda for Sustainable Development" at New Delhi on 21 November 2017, Mr. (...) Access to medicines and medical products is key to universal health coverage.” (...) Specific subjects for discussion at the Conference include access to medical products, innovation and research and development to achieve SDGs, and intellectual property rights and trade for SDGs.
Language:English
Score: 837123.1 - https://www.who.int/india/news...onal-laws-for-trade-and-health
Data Source: un
The use of this falsified Uni-Gold™ HIV, subject of WHO medical product alert n°2 of 2020, is likely to lead to delayed diagnosis of HIV status. Table 1: Specific details of the falsified product Uni-Gold™ HIV, subject of WHO Medical Product Alert n°2 of 2020 Product Name Uni-Gold™ HIV Uni-Gold™ HIV Product code 1206502 1206502 Lot Number HIV7120026 HIV6120030 Expiry Date 5 DEC 2020 29 JUL 20 Stated manufacturer Trinity Biotech Trinity Biotech  The packaging of this falsified HIV test kit is in English. (...) Please contact Trinity Biotech plc Phone : +353 1 276 9800 E-mail : [email protected] Please contact your national health authorities All medical products must be obtained from authentic and reliable sources.
Language:English
Score: 837096.9 - https://www.who.int/news/item/...medical-product-alert-n-2-2020
Data Source: un
Select language Select language English South-East Asia India Home Health topics Our work News Emergencies About us Home / News / Detail / World Conference on Access to Medical Products: Achieving the SDGs 2030 World Conference on Access to Medical Products: Achieving the SDGs 2030 21 November 2019 Highlights 21 November 2019, New Delhi : India has always been a health-aware country and believed in the principles of ‘Panchtatva’  that  connotes the five elements i.e.  (...) Dr Harsh Vardhan, Union Health Minister, Ministry of Family & Health Welfare, during his inaugural address announced the dates of the 2020 World Conference to be hosted in India from 23-25 September; and affirmed the government’s commitment to keep the momentum going on pertinent and contemporary issues surrounding accessibility, affordability and viability of medical products. The prominent dignitaries present at the occasion, while the curtains came down on the 2019 World Conference on Access to Medical Products were Mr. (...) The key focus areas of discussion on the concluding day of the conference were: Patent Landscaping for Health Products, Access strategies, Patent Pool Mechanisms, Licensing for Medical Products and Health Technologies including the Role of Pharmaceutical Sector.
Language:English
Score: 836969.3 - https://www.who.int/india/news...-on-access-to-medical-products
Data Source: un
No country produces all the products needed for medical care or the necessary intermediate products. (...) Since 1 April 2020, all exports of medical products including Covid- 19 testing kits, medical face masks, medical protective suits, ventilators, and infrared thermometers must be accompanied by proof of registration with the National Medical Products Administration (NMPA). (...) This is particularly relevant for the production of medicines, medical equipment, and medical consumables.
Language:English
Score: 836049.3 - https://www.wto.org/english/tr..._e/covid19_e/bdi_covid19_e.pdf
Data Source: un
As a result of the publication of Medical Product Alert n°5/2020 the WHO was informed falsified DEFIBROTIDE 200MG vials with batch number 0286 was supplied to Argentina. (...) If you are in possession of the above products, please do not use them. If you have used these falsified products, or if you suffer an adverse reaction/event having used these products, you are advised to seek immediate medical advice from a qualified healthcare professional, and to report the incident to the National Regulatory Authorities/National Pharmacovigilance Centre. All medical products must be obtained from licensed, authorized and reliable sources.
Language:English
Score: 835943.3 - https://www.who.int/news/item/...medical-product-alert-n-5-2020
Data Source: un
WHO requests increased vigilance within the supply chains of countries and regions likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies, and any other suppliers of medical products. All medical products, including COVID-19 vaccines, must be obtained from authorized/licensed suppliers and authorized immunization programmes. (...) If you are in possession of the above-falsified products, please do not use them. If you have used these products, or you suffered an adverse reaction/event having used these products, you are advised to seek immediate medical advice from a qualified healthcare professional and to report the incident to the National Regulatory Authorities / National Pharmacovigilance Centre.
Language:English
Score: 835906.25 - https://www.who.int/news/item/...d-covid-19-vaccine-astrazeneca
Data Source: un